Impaired Glucose Tolerance
📧 Sign up to get email alerts when something new happens for Impaired Glucose Tolerance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: Age, Lifestyle, Muscle Mechanisms in Insulin Resistance [NA]
The clinical trial studying age, lifestyle, and muscle mechanisms in insulin resistance has completed. It was sponsored by the National Inst…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay [Phase 3]
Phase 3 trial update evaluating slow-release insulin in cystic fibrosis patients with impaired glucose tolerance; the current status of the …
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients [Phase 3]
A Phase 3 clinical trial evaluating the effect of rosiglitazone and ramipril on pre-clinical vasculopathy in patients with diabetes and impa…
-
CLINICAL_TRIALS research · 2009-06-23Clinical Trial Update: Type 2 Diabetes and Acute Myocardial Infarction
Clinical trial update examining the interplay between Type 2 diabetes mellitus and acute myocardial infarction, with impaired glucose tolera…
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome [Phase 3]
Phase 3 trial assessing whether L-Arginine can prevent progression to Type 2 Diabetes Mellitus in people with metabolic syndrome and impaire…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-03-02Clinical Trial Update: Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons [NA]
Clinical trial update examining the effects of exercise on cardiovascular risk factors, quality of life, and muscle function in people with …
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated escalating doses of a novel viscous polysaccharide for reducing postprandial blood glucose, and t…
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: The Study of Atherosclerosis With Ramipril and Rosiglitazone [Phase 3]
Phase 3 trial evaluating ramipril and rosiglitazone for atherosclerosis in individuals with impaired glucose tolerance; the study has comple…
-
CLINICAL_TRIALS research · 2008-08-25Clinical Trial Update: Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. [NA]
This clinical trial update describes an intervention being evaluated for impaired glucose tolerance in patients with coronary heart disease,…
-
CLINICAL_TRIALS research · 2008-08-12Clinical Trial Update: Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance [Phase 4]
Phase 4 clinical trial update evaluating rosiglitazone for prevention of coronary artery disease in patients with impaired glucose tolerance…
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: Cognitive Effects of Aerobic Exercise for IGT Adults [Phase 2]
Phase 2 clinical trial evaluating whether aerobic exercise improves cognitive function in adults with impaired glucose tolerance. The study …
-
CLINICAL_TRIALS trial_result · 2008-04-25Clinical Trial Update: Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance [Phase 4]
Phase 4 clinical trial evaluating the effects of insulin-sensitizing drugs in subjects with impaired glucose tolerance and diabetes; the stu…
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial [Phase 3]
Phase 3 STOP-NIDDM trial update examining metabolic syndrome risk factors in individuals with impaired glucose tolerance.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes
A completed clinical trial evaluating the health effects of liposuction in overweight women with elevated insulin levels, impaired glucose t…
-
CLINICAL_TRIALS trial_result · 2007-11-20Clinical Trial Update: Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance [Phase 3]
This update notes the completion of a Phase 3 clinical trial evaluating a vanadium supplement in adults with impaired glucose tolerance (pre…
-
CLINICAL_TRIALS trial_result · 2007-05-11Clinical Trial Update: The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients [NA]
Clinical trial update examining the effects of exercise on adipokine levels in adults with impaired fasting glucose or impaired glucose tole…
-
CLINICAL_TRIALS research · 2007-01-04Clinical Trial Update: Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes [NA]
A clinical trial update suggests that acarbose combined with alcohol may lead to additional glucose lowering and anti-inflammatory effects i…
-
CLINICAL_TRIALS trial_result · 2006-12-05Clinical Trial Update: Telmisartan and Losartan in Hypertensive IGT [Phase 4]
Phase 4 clinical trial update showing completion of a study evaluating telmisartan and losartan in patients with hypertension and impaired g…
-
CLINICAL_TRIALS trial_result · 2006-07-14Clinical Trial Update: Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults [Phase 4]
Phase 4 clinical trial assessing the effects of human growth hormone and pioglitazone in overweight, prediabetic adults has completed. The s…
-
CLINICAL_TRIALS trial_result · 2006-05-10Clinical Trial Update: Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients [Phase 4]
Phase 4 trial assessing the efficacy and safety of nateglinide in renal transplant recipients with posttransplant diabetes mellitus or impai…